# Ionosol MB and Dextrose

NDC: 0990-7372
Generic name: DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, and SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Labeler / Manufacturer: ICU Medical Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190701

FDA application: NDA019513

## Active ingredients

- DEXTROSE MONOHYDRATE: 5 g/100mL
- MAGNESIUM CHLORIDE: 30 mg/100mL
- MONOBASIC POTASSIUM PHOSPHATE: 15 mg/100mL
- POTASSIUM CHLORIDE: 141 mg/100mL
- SODIUM LACTATE: 260 mg/100mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 25 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0990-7372"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0990-7372
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b457b1d-0e80-4578-ba6f-dedf513fc962